OTLK
OUTLOOK THERAPEUTICS INC
NASDAQ: OTLK · HEALTHCARE · BIOTECHNOLOGY
$0.25
-2.50% today
Updated 2026-04-30
Market cap
$34.41M
P/E ratio
—
P/S ratio
167.29x
EPS (TTM)
$-2.89
Dividend yield
—
52W range
$0 – $3
Volume
3.6M
OUTLOOK THERAPEUTICS INC (OTLK) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
1,116.00%
ROE
-3.65%
ROA
-209.00%
Debt/equity
-0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $9.05M | $-13.73M | 99.84% | -136.91% | -151.72% |
| 2015 | $5.22M | $-47.39M | 99.26% | -892.18% | -908.09% |
| 2016 | $2.98M | $-53.30M | 98.89% | -1,723.05% | -1,788.66% |
| 2017 | $3.81M | $-38.85M | 99.36% | -941.24% | -1,019.12% |
| 2018 | $3.09M | $-30.09M | 99.39% | -959.97% | -974.48% |
| 2019 | $8.15M | $-34.52M | -192.23% | -445.61% | -423.82% |
| 2020 | $5.85M | $-35.24M | -9.47% | -629.38% | -602.01% |
| 2021 | $0.00 | $-53.16M | — | — | — |
| 2022 | $0.00 | $-66.05M | — | — | — |
| 2023 | $0.00 | $-58.98M | — | — | — |
| 2024 | $170124.00 | $-75.37M | -66.93% | -42,147.49% | -44,301.22% |
| 2025 | $1.41M | $-62.42M | 46.49% | -4,744.25% | -4,416.22% |